학술논문
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following Brexit
Document Type
Review Article
Author
Source
In The Lancet Oncology April 2023 24(4):e150-e160
Subject
Language
ISSN
1470-2045